HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Kuroda Selected Research

N-acetyltalosaminuronic acid (NAT)

1/2018Boundary EEG Asymmetry Is Associated to Linguistic Competence in Vascular Cognitive Impairments.
1/2017Altered Neuronal Activity Topography Markers in the Elderly with Increased Atherosclerosis.
10/2014Neuronal activity topography parameters as a marker for differentiating vascular cognitive impairment in carotid stenosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Kuroda Research Topics

Disease

21Moyamoya Disease (Moya-Moya Disease)
02/2021 - 12/2004
21Ischemic Stroke
10/2020 - 12/2008
16Stroke (Strokes)
01/2021 - 10/2002
15Ischemia
03/2015 - 01/2003
14Hemorrhage
01/2021 - 01/2013
14Carotid Stenosis (Carotid Artery Stenosis)
10/2020 - 02/2005
14Aneurysm (Aneurysms)
09/2020 - 01/2005
14Cerebral Infarction
01/2017 - 09/2003
14Infarction (Infarctions)
06/2016 - 03/2004
13Brain Infarction
01/2017 - 03/2004
8Pathologic Constriction (Stenosis)
10/2020 - 01/2005
7Neoplasms (Cancer)
08/2022 - 11/2006
7Brain Ischemia (Cerebral Ischemia)
01/2021 - 03/2004
7Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2018 - 09/2003
6Carotid Artery Diseases
01/2017 - 06/2004
6Spinal Cord Injuries (Spinal Cord Injury)
05/2014 - 09/2003
4Parkinson Disease (Parkinson's Disease)
10/2021 - 01/2014
4Hypertension (High Blood Pressure)
01/2021 - 06/2012
4Glioma (Gliomas)
03/2019 - 09/2011
4Cognitive Dysfunction
01/2017 - 10/2007
4Nervous System Diseases (Neurological Disorders)
01/2013 - 08/2004
4Central Nervous System Diseases (CNS Diseases)
06/2011 - 04/2010
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
09/2020 - 03/2015
3Rupture
09/2020 - 09/2006
3Lacunar Stroke
10/2019 - 01/2013
3Glioblastoma (Glioblastoma Multiforme)
03/2019 - 01/2015
3Brain Neoplasms (Brain Tumor)
08/2018 - 11/2006
3Cysts
05/2018 - 10/2016
3Inflammation (Inflammations)
12/2017 - 06/2010
3Hematoma
01/2017 - 09/2008
3Traumatic Brain Injuries (Traumatic Brain Injury)
04/2012 - 04/2010
3Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
06/2011 - 11/2004
3Ruptured Aneurysm
03/2010 - 09/2006
2Astrocytoma (Pilocytic Astrocytoma)
01/2022 - 08/2018
2COVID-19
01/2021 - 12/2020
2Paresis (Hemiparesis)
10/2020 - 01/2010
2Coronary Artery Disease (Coronary Atherosclerosis)
10/2019 - 02/2005
2Disease Progression
02/2019 - 01/2018
2Transient Ischemic Attack
01/2018 - 09/2007
2Arteriovenous Malformations (Arteriovenous Malformation)
01/2014 - 11/2004
2Thrombosis (Thrombus)
01/2012 - 01/2011
2Intracranial Aneurysm (Cerebral Aneurysm)
01/2011 - 03/2005
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2010 - 02/2008
2Infections
06/2008 - 01/2005
1Adenoma (Adenomas)
08/2022

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2004
7Therapeutic UsesIBA
10/2020 - 04/2010
7Oxygen (Dioxygen)IBA
09/2014 - 12/2003
6Biological ProductsIBA
04/2018 - 11/2004
6Acetazolamide (Diamox)FDA LinkGeneric
11/2013 - 12/2003
5LipidsIBA
01/2021 - 01/2013
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2016 - 05/2009
5Neuroprotective AgentsIBA
03/2016 - 03/2004
4Protein Kinases (Protein Kinase)IBA
03/2019 - 01/2018
4Glucose (Dextrose)FDA LinkGeneric
01/2013 - 09/2009
3Phenobarbital (Luminal)FDA Link
10/2020 - 02/2019
3Pharmaceutical PreparationsIBA
03/2019 - 03/2015
3N-acetyltalosaminuronic acid (NAT)IBA
01/2018 - 10/2014
3Alprostadil (Muse)FDA LinkGeneric
01/2018 - 01/2015
3EdaravoneIBA
07/2016 - 12/2004
3Free Radical ScavengersIBA
07/2016 - 12/2004
3triphenyltetrazoliumIBA
01/2005 - 03/2004
2Keratins (Keratin)IBA
08/2022 - 10/2016
23-Iodobenzylguanidine (Iobenguane)IBA
10/2021 - 01/2016
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2019 - 01/2011
2OTS964IBA
03/2019 - 01/2018
2Temozolomide (Temodar)FDA LinkGeneric
03/2019 - 01/2015
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2018 - 12/2016
2Biomarkers (Surrogate Marker)IBA
06/2018 - 04/2018
2Green Fluorescent ProteinsIBA
01/2018 - 01/2013
2Polyglycolic Acid (Polyglycolide)IBA
05/2017 - 03/2005
2Fibrin Tissue Adhesive (Fibrin Sealant)IBA
05/2017 - 03/2005
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2017 - 09/2014
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2013 - 01/2011
2Bovine Serum AlbuminIBA
09/2011 - 06/2011
2Aligeron (AS 2)IBA
08/2009 - 05/2009
2Superoxides (Superoxide)IBA
12/2008 - 12/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008 - 12/2004
2Cytochromes c (Cytochrome c)IBA
03/2004 - 01/2003
1Perilipin-2IBA
08/2022

Therapy/Procedure

29Therapeutics
01/2021 - 07/2004
25Transplantation
01/2018 - 09/2003
14Carotid Endarterectomy
01/2019 - 01/2005
10Craniotomy
04/2020 - 05/2004
6Cell Transplantation
01/2018 - 10/2007
6Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018 - 01/2010
5Operative Surgical Procedures
01/2021 - 09/2006
5Ligation
07/2017 - 01/2005
4Stents
03/2016 - 02/2005
4Deep Brain Stimulation
01/2016 - 01/2014
3Drug Therapy (Chemotherapy)
01/2022 - 02/2011
3Transcranial Direct Current Stimulation
10/2021 - 01/2018
3Radiotherapy
08/2018 - 10/2002
2Perioperative Period
09/2020 - 08/2014
2Sutures (Suture)
05/2017 - 11/2006
2Aftercare (After-Treatment)
10/2016 - 08/2012
2Decompression
03/2015 - 01/2012
2Endovascular Procedures
11/2011 - 04/2004
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2010 - 02/2008
2Cerebral Revascularization
01/2010 - 11/2008